Support Moving Up In Mannkind Corporation

by Hal Lindon, Benzinga Editor
September 30, 2015 1:47 PM | 17 seconds read | Make a Comment
Loading...
Loading...
  • Mannkind Corproation MNKD has lost 58 percent since its June 9 high ($7.32).
  • Company relies on one drug (Alfreeza) for most of its revenue.
  • Bottomed on Monday at $3, Tuesday at $3.03 and today at $3.05.
  • Peaked in today's session $0.02 ahead of Tuesday's high at $3.30.
    • Market News and Data brought to you by Benzinga APIs

    © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    Posted In: TechnicalsIntraday UpdateTrading Ideas
    Benzinga simplifies the market for smarter investing

    Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

    Join Now: Free!